These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 34432543)

  • 61. Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil.
    Carvalho VM; de Almeida FG; de Macêdo Vieira AC; Rocha ED; Cabral LM; Strongin RM
    Forensic Sci Int; 2022 Jun; 335():111309. PubMed ID: 35462181
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.
    Aishworiya R; Valica T; Hagerman R; Restrepo B
    Neurotherapeutics; 2022 Jan; 19(1):248-262. PubMed ID: 35029811
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.
    Sakal C; Lynskey M; Schlag AK; Nutt DJ
    Psychopharmacology (Berl); 2022 May; 239(5):1147-1155. PubMed ID: 33970291
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry.
    Ergisi M; Erridge S; Harris M; Kawka M; Nimalan D; Salazar O; Loupasaki K; Ali R; Holvey C; Coomber R; Usmani A; Sajad M; Beri S; Hoare J; Khan SA; Weatherall MW; Platt M; Rucker JJ; Sodergren MH
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):557-566. PubMed ID: 35073160
    [No Abstract]   [Full Text] [Related]  

  • 65. Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry.
    Erridge S; Kerr-Gaffney J; Holvey C; Coomber R; Barros DAR; Bhoskar U; Mwimba G; Praveen K; Symeon C; Sachdeva-Mohan S; Sodergren MH; Rucker JJ
    Ther Adv Psychopharmacol; 2022; 12():20451253221116240. PubMed ID: 36159065
    [TBL] [Abstract][Full Text] [Related]  

  • 66. "Is medical cannabis safe for my patients?" A practical review of cannabis safety considerations.
    MacCallum CA; Lo LA; Boivin M
    Eur J Intern Med; 2021 Jul; 89():10-18. PubMed ID: 34083092
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder.
    Henneberry E; Lamy M; Dominick KC; Erickson CA
    J Autism Dev Disord; 2021 Dec; 51(12):4370-4394. PubMed ID: 34491511
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders.
    Duvall SW; Lindly O; Zuckerman K; Msall ME; Weddle M
    Pediatrics; 2019 Feb; 143(2):. PubMed ID: 30610100
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies.
    Fusar-Poli L; Cavone V; Tinacci S; Concas I; Petralia A; Signorelli MS; Díaz-Caneja CM; Aguglia E
    Brain Sci; 2020 Aug; 10(9):. PubMed ID: 32825313
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Retrospective Chart Review of Buspirone for the Treatment of Anxiety in Psychiatrically Referred Youth with High-Functioning Autism Spectrum Disorder.
    Ceranoglu TA; Wozniak J; Fried R; Galdo M; Hoskova B; DeLeon Fong M; Biederman J; Joshi G
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):28-33. PubMed ID: 30452283
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
    JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder.
    Pandina G; Ring RH; Bangerter A; Ness S
    Child Adolesc Psychiatr Clin N Am; 2020 Apr; 29(2):301-317. PubMed ID: 32169264
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
    Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
    Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.
    Hurwitz R; Blackmore R; Hazell P; Williams K; Woolfenden S
    Cochrane Database Syst Rev; 2012 Mar; (3):CD008372. PubMed ID: 22419332
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effectiveness of self-directed medical cannabis treatment for pain.
    Li X; Vigil JM; Stith SS; Brockelman F; Keeling K; Hall B
    Complement Ther Med; 2019 Oct; 46():123-130. PubMed ID: 31519268
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications.
    Schubert EA; Alffenaar JC; Johnstone MT; Barlow JW; Wheate NJ
    Int J Pharm Pract; 2023 Mar; 31(1):70-79. PubMed ID: 36445409
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder.
    Zimmerman AW; Singh K; Connors SL; Liu H; Panjwani AA; Lee LC; Diggins E; Foley A; Melnyk S; Singh IN; James SJ; Frye RE; Fahey JW
    Mol Autism; 2021 May; 12(1):38. PubMed ID: 34034808
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.
    Aye SZ; Ni H; Sein HH; Mon ST; Zheng Q; Wong YKY
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013457. PubMed ID: 33583058
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of Antipsychotic Use on Readmission Rates in Children and Adolescents With Autism Spectrum Disorder and Irritability.
    Kompella S; Vittori A; Kroin J; Kaushal S; Khan S; Neuhut S
    Cureus; 2022 Feb; 14(2):e22361. PubMed ID: 35321066
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: A study of eight patients.
    Caraballo R; Valenzuela GR
    Seizure; 2021 Nov; 92():238-243. PubMed ID: 34624613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.